Back
Viking Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
38
VKTX
Viking Therapeutics, Inc.
Last Price:
$34.79
Seasonality Move:
9.75%
7 Day Trial
ALL ACCESS PASS
$
7
Viking Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Viking Therapeutics, Inc. has on average historically risen by 105.1% based on the past 10 years of stock performance.
-
Viking Therapeutics, Inc. has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Viking Therapeutics, Inc. Stock Undervalued?The current Viking Therapeutics, Inc. [VKTX] share price is $34.80. The Score for VKTX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
VKTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Viking Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Viking Therapeutics, Inc. has on average historically risen by 105.1% based on the past 10 years of stock performance.
Viking Therapeutics, Inc. Stock Rating
Sell
38
Viking Therapeutics, Inc. (VKTX)
is a Sell
Is Viking Therapeutics, Inc. overpriced?
-
Viking Therapeutics, Inc. has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Viking Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vikingtherapeutics.com
52-Week Data
52-Week High:
43.15
52-Week Low:
18.92
Prediction Charts
Market Cap:
4.2B
Price in USD:
34.80
Volume:
3.6M
Beta:
1.32
Technical Analysis
SMA50:
32.06
SMA100:
33.83
SMA200:
32.22
52-Wk Change:
35.51%
Stock Predictions
-
Is Viking Therapeutics, Inc. stock public?Yes, Viking Therapeutics, Inc. is a publicly traded company.
-
What is the Viking Therapeutics, Inc. stock quote today?The Viking Therapeutics, Inc. stock price is 34.80 USD today.
-
How to buy Viking Therapeutics, Inc. stock online?You can buy Viking Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-16 | 35.30 | 36.01 | 36.63 | 35.08 |
| Mar-17 | 35.79 | 35.53 | 36.35 | 35.13 |
| Mar-18 | 35.26 | 33.55 | 35.39 | 33.25 |
| Mar-19 | 33.00 | 33.92 | 34.50 | 32.70 |
| Mar-20 | 33.62 | 32.33 | 34.38 | 31.49 |
| Mar-23 | 32.34 | 32.55 | 33.59 | 32.32 |
| Mar-24 | 32.38 | 32.17 | 32.76 | 31.71 |
| Mar-25 | 32.48 | 33.20 | 33.76 | 32.48 |
| Mar-26 | 32.58 | 34.25 | 34.79 | 32.32 |
| Mar-27 | 33.99 | 32.52 | 34.25 | 32.30 |
| Mar-30 | 32.66 | 29.92 | 32.66 | 29.88 |
| Mar-31 | 30.33 | 32.54 | 33.29 | 30.33 |
| Apr-1 | 32.80 | 32.96 | 33.91 | 32.67 |
| Apr-2 | 32.10 | 34.80 | 35.19 | 32.00 |
Viking Therapeutics, Inc. Earnings
Viking Therapeutics, Inc. Earnings Report: Per Share Viking Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Viking Therapeutics, Inc. Forecast Revenue Growth
Viking Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Viking Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.39 per share, an increase next quarter of $0.09 per share, a decrease this year of $1.43 per share, and a decrease next year of $0.42 per share.
* Viking Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.